Related Experiment Video
Updated: Aug 25, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
The High Expression of Adhering and Circulating Integrin Serves as a Diagnostic Marker in Venous Thromboembolism
Fan Yang1, Yanli Song2, Haoming Song3
1Department of Clinical Laboratory, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.
Insights
Circulating integrins beta1, beta2, and beta3 show promise as biomarkers for diagnosing venous thromboembolism (VTE). Elevated levels in serum and on cells indicate high diagnostic accuracy for VTE detection.
Area of Science:
- Biochemistry
- Hematology
- Medical Diagnostics
Background:
- Venous thromboembolism (VTE) poses a significant health risk.
- Accurate and early diagnosis of VTE is crucial for effective treatment.
- Integrins play roles in cellular adhesion and immune responses, potentially relevant to thrombosis.
Purpose of the Study:
- To evaluate the diagnostic utility of circulating integrins beta1, beta2, and beta3 in patients with VTE.
- To determine the correlation between circulating and adhering integrin levels in VTE.
- To assess the sensitivity and specificity of these integrins as VTE biomarkers.
Main Methods:
- Flow cytometry was used to measure adhering integrins beta1, beta2, and beta3 on leukocytes and platelets.
- Enzyme-linked immunosorbent assay (ELISA) quantified circulating integrins beta1, beta2, and beta3 in serum.
- A cohort of 474 VTE patients and 306 controls was analyzed.
Main Results:
- Significantly higher levels of integrins beta1, beta2, and beta3 were observed in the serum and on the surface of leukocytes and platelets in VTE patients.
- Positive correlations were found between circulating and adhering integrin levels.
- Circulating integrins demonstrated excellent clinical diagnostic performance for VTE.
Conclusions:
- Integrin subunit beta (specifically beta1, beta2, and beta3) shows potential as a diagnostic marker for VTE.
- These circulating integrins offer high sensitivity and specificity for venous thromboembolism diagnosis.
- Further research may establish integrins as reliable biomarkers for VTE.
Objective:
To investigate the diagnostic value of circulating integrins β1, 2, and 3 in venous thrombosis (VTE).
Materials And Methods:
A total of 474 VTE patients and 306 patients with nonhigh risk for VTE as the control group were studied. Levels of adhering integrins β1, 2, and 3 were detected by flow cytometry. Levels of circulating integrins β1, 2, and 3 in serum were measured by enzyme-linked immunosorbent assay.
Results:
We found that integrins β1, 2, and 3 were expressed highly both in serum and on the surface of leukocytes and platelets in venous thromboembolism. The levels of circulating integrins β1, 2, and 3 are positively correlated with adhering integrins. It showed excellent clinical diagnostic performance of circulating integrins β1, 2, and 3 in venous thromboembolism.
Conclusions:
Integrin subunit β can be used as a diagnostic marker with high sensitivity and specificity for venous thromboembolism.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Intracellular Signaling Affects Focal Adhesions
Some...
Venous Thrombosis III: Interprofessional Care
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Varicose Veins II: Diagnostic Studies and Interprofessional Care

